Independent validation of the International Metabolic Prognostic Index (CAR-IMPI) in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T.

Saved in:
Bibliographic Details
Title: Independent validation of the International Metabolic Prognostic Index (CAR-IMPI) in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T.
Authors: Galli E; Department of Laboratory and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Guarneri A; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Corrente A; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Portonera FM; Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Gargarella ER; Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Pansini I; Department of Laboratory and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Chiusolo P; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Sorà F; Department of Laboratory and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Calcagni ML; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.; Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Sica S; Department of Laboratory and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Hohaus S; Department of Laboratory and Hematological Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy., Leccisotti L; Unit of Nuclear Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Section of Hematology, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.; Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, Rome, Italy.
Source: British journal of haematology [Br J Haematol] 2026 Sep 16. Date of Electronic Publication: 2026 Sep 16.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2141
DOI:10.1111/bjh.70846